Table 2.

Univariate and multivariate analysis of prognostic factors for overall survival in LUAD patients

	Univariate analysis			Multivariate analysis
	HR	p value	95% CI	HR	p value	95% CI
MAGE-A1 expression
High versus low	1.78	0.022*	1.09–2.93	1.58	0.087	0.93–2.68
Gender
Male versus female	1.38	0.183	0.86–2.20
Age
≥ 60 years versus < 60 years	0.96	0.861	0.59–1.55
Tumor diameter
≥ 3 cm versus < 3 cm	1.54	0.090	0.93–2.55
Pathological grade
Grade I–II versus grade III	0.88	0.633	0.53–1.47
Lymph node metastasis
Positive versus negative	2.47	0.001*	1.49–4.09	1.02	0.950	0.44–2.42
T status
T1–T2 versus T3–T4	0.71	0.196	0.42–1.20
N status
Positive versus negative	2.11	0.002*	1.31–3.41	1.42	0.265	0.77–2.65
M status
Positive versus negative	1.09	0.930	0.15–7.90
TNM stage
Stage I–II versus stage III–IV	0.36	0.001*	0.21–0.59	0.45	0.029*	0.22–0.92

HR hazard ration, CI confidence interval, LUAD lung adenocarcinoma

*p < 0.05